A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: principles (564), values (295)

InP-Cisplatin-Doxorubicin-Methotrexate (1-4)

Description
Chemotherapy Protocol Sarcoma CISPLATIN-DOXORUBICIN-METHOTREXATE (cycles 1-4) Inpatient Regimen There are multiple versions of this protocol in use. Please
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Cisplatin-Doxorubicin-Methotrexate-1-4.pdf

Radioactive seed implants for prostate cancer low dose rate brachytherapy - patient information

Description
Radioactive seed implants (low dose rate brachytherapy) are a way of using radiotherapy to treat prostate cancer that is contained within
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Radioactive-seed-implants-for-prostate-cancer-low-dose-rate-brachytherapy-954-PIL.pdf

Bevacizumab (7.5mgkg), Carboplatin(AUC5) and Paclitaxel (21 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (7.5)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Ovary-Bevacizumab (7.5)-Carboplatin (AUC5)-Paclitaxel (21
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab7.5mgkgCarboplatinandPaclitaxel21day.pdf

Carboplatin-Vinorelbine Oral

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC6)-VINORELBINE (Oral) Regimen  NSCLC – Carboplatin (AUC6)-Vinorelbine (Oral) Indication  First line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-Oral.pdf

Carboplatin(AUC6)-Pemetrexed

Description
Chemotherapy Protocol MESOTHELIOMA CARBOPLATIN (AUC6)-PEMETREXED Regimen • Mesothelioma – Carboplatin (AUC6)-Pemetrexed Indication • First line therapy of advanced pleural mesothelioma where the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/CarboplatinAUC6-Pemetrexed-Ver1.5.pdf

Carboplatin and Pemetrexed

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-PEMETREXED Regimen • NSCLC – Carboplatin-Pemetrexed Indication • First line therapy of stage IIIB
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Pemetrexed-Ver1.4.pdf

Carboplatin (AUC5) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat (AUC5) Regimen • Ovary – Carboplatin (AUC5) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Retreat.pdf

Bevacizumab (15) Carboplatin-Paclitaxel (21 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Bevacizumab (15)-Carboplatin (AUC5)-Paclitaxel (21 day) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/Bevacizumab-15-Carboplatin-Paclitaxel-21-day.pdf

Azacitidine Oral

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA -AZACITADINE (ORAL) Regimen • AML – AZACITADINE (ORAL) Indication Oral azacitidine as maintenance therapy in newly diagnosed AML
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine-Oral.pdf

Cytarabine(SC)-Venetoclax

Description
Chemotherapy Protocol Acute Myeloid Leukaemia CYTARABINE (SC) - VENETOCLAX Regimen  AML – Cytarabine (SC) -Venetoclax Indication  Newly diagnosed acute myeloid leukaemia (AML).  Patient
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/CytarabineSC-Venetoclax.pdf
361 to 370 of 427
Previous … 35 36 37 38 39 … Next